Press-release for stocks for SNY

symbols : SNY source : Www.globenewswire.com

save search

89bio Appoints Biotech Industry Veteran, Martin Babler to its Board of Directors
Published: 2024-04-17 (Crawled : 20:00) - globenewswire.com
SNYNF | News | $92.7 -2.18% 1.4K

Health Technology

| 0.0% | O: 0.0% H: 0.0% C: 0.0%
SNY | News | $45.395 -1.55% -1.58% 4.4M

Health Technology

| -1.81% | O: -1.81% H: 0.0% C: 0.0%
biotech

IGM Biosciences Announces Refocusing of Sanofi Collaboration
Published: 2024-04-17 (Crawled : 13:00) - globenewswire.com
SNYNF | News | $92.7 -2.18% 1.4K

Health Technology

| 0.63% | O: 0.12% H: 0.51% C: 0.51%
SNY | News | $45.395 -1.55% -1.58% 4.4M

Health Technology

| -0.78% | O: 1.05% H: 0.0% C: 0.0%
IGMS | $7.4 -8.98% -9.86% 450K

Health Technology

| -19.46% | O: 1.85% H: 0.0% C: -13.23%
collaboration sanofi

Press Release: New 48-week frexalimab phase 2 data support potential for high sustained efficacy in multiple sclerosis
Published: 2024-04-17 (Crawled : 05:00) - globenewswire.com
SNYNF | News | $92.7 -2.18% 1.4K

Health Technology

| 0.63% | O: 0.12% H: 0.51% C: 0.51%
SNY | News | $45.395 -1.55% -1.58% 4.4M

Health Technology

| -0.78% | O: 1.05% H: 0.0% C: 0.0%
sclerosis for potential

Sanofi: Information concerning the total number of voting rights and shares - March 2024
Published: 2024-04-12 (Crawled : 18:00) - globenewswire.com
SNY | News | $45.395 -1.55% -1.58% 4.4M

Health Technology

| Email alert Add to watchlist
SNYNF | News | $92.7 -2.18% 1.4K

Health Technology

| Email alert Add to watchlist
total

IGM Biosciences to Present at the Stifel 2024 Virtual Targeted Oncology Forum
Published: 2024-04-10 (Crawled : 11:00) - globenewswire.com
SNYNF | News | $92.7 -2.18% 1.4K

Health Technology

| -1.65% | O: -0.01% H: 0.0% C: 0.0%
SNY | News | $45.395 -1.55% -1.58% 4.4M

Health Technology

| -4.25% | O: -0.32% H: 0.0% C: 0.0%
IGMS | $7.4 -8.98% -9.86% 450K

Health Technology

| -15.99% | O: -0.91% H: 0.0% C: -6.41%

Nurix Therapeutics Reports First Quarter Fiscal 2024 Financial Results and Provides a Corporate Update
Published: 2024-04-10 (Crawled : 11:00) - globenewswire.com
SNYNF | News | $92.7 -2.18% 1.4K

Health Technology

| -1.65% | O: -0.01% H: 0.0% C: 0.0%
SNY | News | $45.395 -1.55% -1.58% 4.4M

Health Technology

| -4.25% | O: -0.32% H: 0.0% C: 0.0%
NRIX | $14.43 2.49% 2.43% 970K

Health Technology

| 2.52% | O: 18.35% H: 1.98% C: -5.88%
first update therapeutics financial results

MoonLake Immunotherapeutics inks three-year technology partnership with Komodo Health to advance research on inflammatory skin and joint conditions
Published: 2024-04-10 (Crawled : 11:00) - globenewswire.com
MLTX | $42.31 -2.76% -2.84% 230K

| -7.25% | O: -2.03% H: 2.45% C: 0.48%
SNYNF | News | $92.7 -2.18% 1.4K

Health Technology

| -1.65% | O: -0.01% H: 0.0% C: 0.0%
SNY | News | $45.395 -1.55% -1.58% 4.4M

Health Technology

| -4.25% | O: -0.32% H: 0.0% C: 0.0%
partnership health research technology skin

Nurix Therapeutics Announces Extension of Strategic Collaboration with Sanofi to Develop Novel Targeted Protein Degraders of STAT6
Published: 2024-04-09 (Crawled : 11:00) - globenewswire.com
SNYNF | News | $92.7 -2.18% 1.4K

Health Technology

| -1.38% | O: 0.28% H: 0.0% C: 0.0%
SNY | News | $45.395 -1.55% -1.58% 4.4M

Health Technology

| -3.83% | O: -0.38% H: 0.95% C: 0.83%
NRIX | $14.43 2.49% 2.43% 970K

Health Technology

| 3.81% | O: 1.26% H: 0.0% C: 0.0%
protein collaboration extension therapeutics sanofi

Sanofi - AGM 30.04.2024 - Availability of Preparatory documents
Published: 2024-04-08 (Crawled : 17:00) - globenewswire.com
SNYNF | News | $92.7 -2.18% 1.4K

Health Technology

| 0.01% | O: 2.24% H: 0.0% C: -0.8%
SNY | News | $45.395 -1.55% -1.58% 4.4M

Health Technology

| -3.02% | O: 0.84% H: 0.0% C: 0.0%
sanofi

Linvoseltamab Pivotal Data Presented at AACR Reinforce High Response Rate that Deepens Over Time in Patients with Heavily Pre-Treated Multiple Myeloma
Published: 2024-04-07 (Crawled : 20:20) - globenewswire.com
SNYNF | News | $92.7 -2.18% 1.4K

Health Technology

| 0.01% | O: 2.24% H: 0.0% C: -0.8%
SNY | News | $45.395 -1.55% -1.58% 4.4M

Health Technology

| -3.02% | O: 0.84% H: 0.0% C: 0.0%
REGN | $893.66 -0.84% -0.84% 450K

Health Technology

| -3.94% | O: 0.11% H: 0.32% C: -0.07%
response

AB Science announces that Health Canada has granted eligibility for reconsideration request for masitinib in ALS
Published: 2024-04-03 (Crawled : 16:00) - globenewswire.com
SNY | News | $45.395 -1.55% -1.58% 4.4M

Health Technology

| -4.59% | O: 0.69% H: 0.0% C: 0.0%
health als granted canada

HUTCHMED and Innovent Jointly Announce NDA Acceptance in China for Fruquintinib Combination with Sintilimab for the Treatment of Advanced Endometrial Cancer with Priority Review Status
Published: 2024-04-02 (Crawled : 05:00) - globenewswire.com
LLY | $745.95 -0.64% -0.1% 1.7M

Health Technology

| -3.34% | O: -2.79% H: 1.32% C: 1.18%
SNY | News | $45.395 -1.55% -1.58% 4.4M

Health Technology

| -6.67% | O: -1.14% H: 0.02% C: -1.06%
HCM | $16.38 -0.43% -0.43% 190K

Health Technology

| -1.47% | O: 0.21% H: 1.49% C: -0.06%
treatment advanced china

Curative Biotechnology, Inc. Announces Nomination of Dr. Theresa Heah to Board of Directors
Published: 2024-03-31 (Crawled : 00:00) - globenewswire.com
CUBT | $0.0269 -42.11% 21K

n/a

| 0.0% | O: 3.57% H: 0.0% C: -6.9%
SNY | News | $45.395 -1.55% -1.58% 4.4M

Health Technology

| -7.58% | O: -0.97% H: 0.0% C: 0.0%

Adagene Reports Full Year 2023 Financial Results and Provides Corporate Update
Published: 2024-03-29 (Crawled : 13:00) - globenewswire.com
SNYNF | News | $92.7 -2.18% 1.4K

Health Technology

| Email alert Add to watchlist
ADAG | $2.53 -0.37% 1.8K

Manufacturing

| Email alert Add to watchlist
SNY | News | $45.395 -1.55% -1.58% 4.4M

Health Technology

| Email alert Add to watchlist
year update financial results

Inventiva announces the nomination of Andre Turenne as Director
Published: 2024-03-28 (Crawled : 07:00) - globenewswire.com
SNYNF | News | $92.7 -2.18% 1.4K

Health Technology

| -7.02% | O: -1.17% H: 0.0% C: -0.89%
SNY | News | $45.395 -1.55% -1.58% 4.4M

Health Technology

| -8.47% | O: -0.96% H: 0.0% C: 0.0%
IVA | $3.28 1.86% 1.83% 12K

Health Technology

| -15.71% | O: -1.83% H: 0.0% C: -3.47%

XORTX Announces New Clinical Advisory Board Member
Published: 2024-03-27 (Crawled : 09:00) - globenewswire.com
SNYNF | News | $92.7 -2.18% 1.4K

Health Technology

| -7.26% | O: -0.26% H: 0.0% C: 0.0%
XRTX | $3.5 -3.05% -3.14% 12K

Mining, Quarrying, and Oil and ...

| 1.84% | O: 0.0% H: 0.0% C: -5.79%
SNY | News | $45.395 -1.55% -1.58% 4.4M

Health Technology

| -7.5% | O: 1.06% H: 0.0% C: 0.0%

Umicore - Notice of ordinary and special shareholders’ meetings
Published: 2024-03-26 (Crawled : 08:00) - globenewswire.com
SNY | News | $45.395 -1.55% -1.58% 4.4M

Health Technology

| -5.72% | O: 1.93% H: 0.0% C: 0.0%

Dyne Therapeutics Announces CEO Transition
Published: 2024-03-25 (Crawled : 12:00) - globenewswire.com
SNYNF | News | $92.7 -2.18% 1.4K

Health Technology

| -1.09% | O: -100.0% H: NaN% C: Infinity%
SNY | News | $45.395 -1.55% -1.58% 4.4M

Health Technology

| -5.33% | O: 0.42% H: 0.0% C: 0.0%
DYN | $23.65 -4.71% -4.95% 980K

Health Technology

| -12.78% | O: -13.24% H: 11.02% C: 6.37%
BIIB | $190.55 -0.84% -0.84% 1.5M

Health Technology

| -10.52% | O: -0.15% H: 0.23% C: -0.5%
ceo therapeutics

Regeneron Provides Update on Biologics License Application for Odronextamab
Published: 2024-03-25 (Crawled : 11:00) - globenewswire.com
SNYNF | News | $92.7 -2.18% 1.4K

Health Technology